Literature DB >> 29885585

Acellular vascular matrix grafts from human placenta chorion: Impact of ECM preservation on graft characteristics, protein composition and in vivo performance.

Karl H Schneider1, Marjan Enayati2, Christian Grasl3, Ingrid Walter4, Lubos Budinsky5, Gabriel Zebic6, Christoph Kaun7, Anja Wagner8, Klaus Kratochwill8, Heinz Redl9, Andreas H Teuschl10, Bruno K Podesser1, Helga Bergmeister11.   

Abstract

Small diameter vascular grafts from human placenta, decellularized with either Triton X-100 (Triton) or SDS and crosslinked with heparin were constructed and characterized. Graft biochemical properties, residual DNA, and protein composition were evaluated to compare the effect of the two detergents on graft matrix composition and structural alterations. Biocompatibility was tested in vitro by culturing the grafts with primary human macrophages and in vivo by subcutaneous implantation of graft conduits (n = 7 per group) into the flanks of nude rats. Subsequently, graft performance was evaluated using an aortic implantation model in Sprague Dawley rats (one month, n = 14). In situ graft imaging was performed using MRI angiography. Retrieved specimens were analyzed by electromyography, scanning electron microscopy, histology and immunohistochemistry to evaluate cell migration and the degree of functional tissue remodeling. Both decellularization methods resulted in grafts of excellent biocompatibility in vitro and in vivo, with low immunogenic potential. Proteomic data revealed removal of cytoplasmic proteins with relative enrichment of ECM proteins in decelluarized specimens of both groups. Noteworthy, LC-Mass Spectrometry analysis revealed that 16 proteins were exclusively preserved in Triton decellularized specimens in comparison to SDS-treated specimens. Aortic grafts showed high patency rates, no signs of thrombus formation, aneurysms or rupture. Conduits of both groups revealed tissue-specific cell migration indicative of functional remodeling. This study strongly suggests that decellularized allogenic grafts from the human placenta have the potential to be used as vascular replacement materials. Both detergents produced grafts with low residual immunogenicity and appropriate mechanical properties. Observed differences in graft characteristics due to preservation method had no impact on successful in vivo performance in the rodent model.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biocompatibility; Cell migration; Decellularized matrix; Human placenta; Small diameter vascular grafts

Mesh:

Substances:

Year:  2018        PMID: 29885585     DOI: 10.1016/j.biomaterials.2018.05.045

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  11 in total

Review 1.  Bioprinting of freestanding vascular grafts and the regulatory considerations for additively manufactured vascular prostheses.

Authors:  Sara Abdollahi; Joseph Boktor; Narutoshi Hibino
Journal:  Transl Res       Date:  2019-06-03       Impact factor: 7.012

2.  Extracellular Matrix for Small-Diameter Vascular Grafts.

Authors:  Megan Kimicata; Prateek Swamykumar; John P Fisher
Journal:  Tissue Eng Part A       Date:  2020-12       Impact factor: 3.845

3.  Preclinical Development of Bioengineered Allografts Derived from Decellularized Human Diaphragm.

Authors:  Silvia Barbon; Elena Stocco; Martina Contran; Federico Facchin; Rafael Boscolo-Berto; Silvia Todros; Deborah Sandrin; Filippo Romanato; Piero Pavan; Veronica Macchi; Vincenzo Vindigni; Franco Bassetto; Raffaele De Caro; Andrea Porzionato
Journal:  Biomedicines       Date:  2022-03-22

Review 4.  Extracellular matrix-derived biomaterials in engineering cell function.

Authors:  Hao Xing; Hudson Lee; Lijing Luo; Themis R Kyriakides
Journal:  Biotechnol Adv       Date:  2019-08-02       Impact factor: 14.227

5.  Designing a novel vacuum aspiration system to decellularize large-size enthesis with preservation of physicochemical and biological properties.

Authors:  Qiang Shi; Yang Chen; Muzhi Li; Tao Zhang; Shulin Ding; Yan Xu; Jianzhong Hu; Can Chen; Hongbin Lu
Journal:  Ann Transl Med       Date:  2020-11

6.  Photooxidation and Pentagalloyl Glucose Cross-Linking Improves the Performance of Decellularized Small-Diameter Vascular Xenograft In Vivo.

Authors:  Yuhong Liu; Chunyang Chen; Xinlong Xie; Haoyong Yuan; Zhenjie Tang; Tao Qian; Yalin Liu; Mingzhe Song; Sixi Liu; Ting Lu; Zhongshi Wu
Journal:  Front Bioeng Biotechnol       Date:  2022-03-24

Review 7.  Failure Analysis of TEVG's I: Overcoming the Initial Stages of Blood Material Interaction and Stabilization of the Immune Response.

Authors:  Maria A Rodriguez-Soto; Natalia Suarez Vargas; Alejandra Riveros; Carolina Muñoz Camargo; Juan C Cruz; Nestor Sandoval; Juan C Briceño
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

8.  Chorion-derived extracellular matrix hydrogel and fibronectin surface coatings show similar beneficial effects on endothelialization of expanded polytetrafluorethylene vascular grafts.

Authors:  Sabrina Rohringer; Karl H Schneider; Gabriela Eder; Pia Hager; Marjan Enayati; Barbara Kapeller; Herbert Kiss; Ursula Windberger; Bruno K Podesser; Helga Bergmeister
Journal:  Mater Today Bio       Date:  2022-04-16

Review 9.  Tissue-Specific Decellularization Methods: Rationale and Strategies to Achieve Regenerative Compounds.

Authors:  Unai Mendibil; Raquel Ruiz-Hernandez; Sugoi Retegi-Carrion; Nerea Garcia-Urquia; Beatriz Olalde-Graells; Ander Abarrategi
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

Review 10.  Failure Analysis of TEVG's II: Late Failure and Entering the Regeneration Pathway.

Authors:  Maria A Rodriguez-Soto; Alejandra Riveros; Natalia Suarez Vargas; Andres J Garcia-Brand; Carolina Muñoz Camargo; Juan C Cruz; Nestor Sandoval; Juan C Briceño
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.